Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001209191-15-042801

10% owner bought 200,000 shares at $12.00 ($2,400,000)

  • 10% owner acquired 3,121,842 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion +3,060,502 3,060,502 I: show line 1 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Purchase +196,070 $12.00 $2,352,840 3,256,572 I: show line 2 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion +61,340 61,340 I: show line 3 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Purchase +3,930 $12.00 $47,160 65,270 I: show line 4 in the form
Open-market purchases · 200,000 sh · avg $12.00 · $2,400,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion · Series B Convertible Preferred Stock −12,837,935 0 I: show line 5 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion · Series B Convertible Preferred Stock −257,303 0 I: show line 6 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion · Series C Convertible Preferred Stock −3,160,905 0 I: show line 7 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion · Series C Convertible Preferred Stock −63,356 0 I: show line 8 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion · Series D Convertible Preferred Stock −5,045,381 0 I: show line 9 in the form
Longitude Capital Partners, LLC 10% owner 2015-05-12 Conversion · Series D Convertible Preferred Stock −101,128 0 I: show line 10 in the form
Loading xslF345X03/doc4.xml…